Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Mcl-1 is a key determinant of breast cancer cell survival


ABSTRACT: This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

ORGANISM(S): Homo sapiens

SUBMITTER: Xin Lu 

PROVIDER: E-GEOD-66072 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor.

Xiao Yu Y   Nimmer Paul P   Sheppard George S GS   Bruncko Milan M   Hessler Paul P   Lu Xin X   Roberts-Rapp Lisa L   Pappano William N WN   Elmore Steven W SW   Souers Andrew J AJ   Leverson Joel D JD   Phillips Darren C DC  

Molecular cancer therapeutics 20150526 8


Hyperexpression of antiapoptotic BCL-2 family proteins allows cells to survive despite the receipt of signals that would ordinarily induce their deletion, a facet frequently exploited by tumors. Tumors addicted to the BCL-2 family proteins for survival are now being targeted therapeutically. For example, navitoclax, a BCL-2/BCL-XL/BCL-W inhibitor, is currently in phase I/II clinical trials in numerous malignancies. However, the related family member, MCL-1, limits the efficacy of navitoclax and  ...[more]

Similar Datasets

2015-08-07 | E-GEOD-66070 | biostudies-arrayexpress
2015-08-07 | E-GEOD-66071 | biostudies-arrayexpress
2015-08-07 | GSE66072 | GEO
2015-08-07 | GSE66071 | GEO
2015-08-07 | GSE66070 | GEO
2013-12-01 | E-GEOD-52434 | biostudies-arrayexpress
2020-03-05 | PXD014423 | Pride
2013-03-31 | E-GEOD-39243 | biostudies-arrayexpress
2015-12-10 | E-GEOD-61060 | biostudies-arrayexpress
2013-02-01 | E-GEOD-34465 | biostudies-arrayexpress